Ultra-processed food and incident type 2 diabetes: studying the underlying consumption patterns to unravel the health effects of this heterogeneous food category in the prospective Lifelines cohort.
Autorzy:
DuanMJ; Department of Internal Medicine, Division Nephrology (AA52), University Medical Center Groningen, P.O. Box 30 001, 9700RB, Groningen, The Netherlands. m.duan@umcg.nl. Vinke PC; Department of Epidemiology (FA40), University Medical Center Groningen, P.O. Box 30 001, 9700RB, Groningen, The Netherlands. Navis G; Department of Internal Medicine, Division Nephrology (AA52), University Medical Center Groningen, P.O. Box 30 001, 9700RB, Groningen, The Netherlands. Corpeleijn E; Department of Epidemiology (FA40), University Medical Center Groningen, P.O. Box 30 001, 9700RB, Groningen, The Netherlands. Dekker LH; Department of Internal Medicine, Division Nephrology (AA52), University Medical Center Groningen, P.O. Box 30 001, 9700RB, Groningen, The Netherlands.; Aletta Jacobs School of Public Health, University of Groningen, P.O. Box 716, 9712GH, Groningen, The Netherlands.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2022 Jan 13; Vol. 20 (1), pp. 7. Date of Electronic Publication: 2022 Jan 13.
MicroRNA-153 impairs presynaptic plasticity by blocking vesicle release following chronic brain hypoperfusion.
Autorzy:
Yan ML; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Zhang S; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Zhao HM; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Xia SN; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Jin Z; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Xu Y; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Yang L; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Qu Y; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Huang SY; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. DuanMJ; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Mao M; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. An XB; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Mishra C; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Zhang XY; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Sun LH; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. Ai J; Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy of Harbin Medical University, Harbin, 150086, Heilongjiang Province, China. .
Overexpression of miR-1 in the heart attenuates hippocampal synaptic vesicle exocytosis by the posttranscriptional regulation of SNAP-25 through the transportation of exosomes.
Autorzy:
DuanMJ; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Yan ML; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Wang Q; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Mao M; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Su D; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Sun LL; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Li KX; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Qu Y; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Sun Q; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Zhang XY; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Huang SY; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Ma JC; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. Ban T; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. . Ai J; Department of Pharmacology, College of Pharmacy of Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin, 150086, Heilongjiang Province, China. .
Factors influencing the routine immunization status of children aged 2-3 years in China.
Autorzy:
Cao L; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China. Zheng JS; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China. Cao LS; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China. Cui J; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China. DuanMJ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China. Xiao QY; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Oct 31; Vol. 13 (10), pp. e0206566. Date of Electronic Publication: 2018 Oct 31 (Print Publication: 2018).
Implementing the communication for development strategy to improve knowledge and coverage of measles vaccination in western Chinese immunization programs: a before-and-after evaluation.
Autorzy:
Lu M; School of Public Health, Fudan University, Shanghai, People's Republic of China. Chu YZ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. Yu WZ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. Scherpbier R; UNICEF Beijing Office, Beijing, People's Republic of China. Zhou YQ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. Zhu X; UNICEF Beijing Office, Beijing, People's Republic of China. Su QR; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. DuanMJ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. Zhang X; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. Cui FQ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. Wang HQ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China. Zhou YB; School of Public Health, Fudan University, Shanghai, People's Republic of China. z_. Jiang QW; School of Public Health, Fudan University, Shanghai, People's Republic of China. .
Pokaż więcej
Źródło:
Infectious diseases of poverty [Infect Dis Poverty] 2017 Apr 24; Vol. 6 (1), pp. 47. Date of Electronic Publication: 2017 Apr 24.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
